|
EIF5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.698400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.722400E-02 |
| Normal-vs-Stage2 |
2.668200E-01 |
| Normal-vs-Stage3 |
6.495600E-02 |
| Normal-vs-Stage4 |
4.560000E-01 |
| Stage1-vs-Stage2 |
9.241000E-01 |
| Stage1-vs-Stage3 |
6.373400E-01 |
| Stage1-vs-Stage4 |
8.740600E-01 |
| Stage2-vs-Stage3 |
6.878600E-01 |
| Stage2-vs-Stage4 |
9.392400E-01 |
| Stage3-vs-Stage4 |
6.937000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.784100E-02 |
| Normal-vs-AfricanAmerican |
3.391600E-02 |
| Normal-vs-Asian |
8.217600E-02 |
| Caucasian-vs-AfricanAmerican |
1.655980E-01 |
| Caucasian-vs-Asian |
5.766400E-01 |
| AfricanAmerican-vs-Asian |
3.956600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.761600E-01 |
| Normal-vs-Female |
3.423700E-02 |
| Male-vs-Female |
4.105200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.436600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.349700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.321200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.848400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.914000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.313200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.304600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.397600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.842200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.611000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.148000E-01 |
| Classical-VS-Follicular |
3.397000E-01 |
| Classical-VS-Other |
7.526400E-01 |
| Classical-VS-Normal |
2.371000E-01 |
| Tall-VS-Follicular |
9.141800E-01 |
| Tall-VS-Other |
9.503800E-01 |
| Tall-VS-Normal |
1.827360E-01 |
| Follicular-VS-Other |
9.999200E-01 |
| Follicular-VS-Normal |
7.738100E-02 |
| Other-VS-Normal |
3.564800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.079630E-02 |
| Normal-vs-N1 |
3.318600E-01 |
| N0-vs-N1 |
6.320600E-01 |
|
|
